Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of sinomenine or pharmaceutically acceptable salt thereof as medicament for preventing and treating pulmonary interstitial fibrosis

A technology of pulmonary interstitial fibrosis and sinomenine, applied in the field of alkaloids, can solve problems such as organ or tissue damage, achieve the effects of preventing occurrence and development, clarifying the chemical structure, and eliminating adverse effects

Active Publication Date: 2012-07-18
李蕴麟
View PDF5 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0056] (2) Pharmacology and adverse reactions of cyclophosphamide
[0064] (3) Pharmacology and adverse reactions of colchicine
Other clinical and experimental studies on the adverse reactions of sinomenine have not found reports of damage to major organs or tissues caused by long-term use of the drug within the therapeutic dose range, thus contradicting the clinical safety of the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of sinomenine or pharmaceutically acceptable salt thereof as medicament for preventing and treating pulmonary interstitial fibrosis
  • Application of sinomenine or pharmaceutically acceptable salt thereof as medicament for preventing and treating pulmonary interstitial fibrosis
  • Application of sinomenine or pharmaceutically acceptable salt thereof as medicament for preventing and treating pulmonary interstitial fibrosis

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0116] Experimental example: Effect of sinomenine on bleomycin-induced pulmonary fibrosis in mice and its mechanism

[0117] Pulmonary fibrosis is a common pathological change of various heterogeneous interstitial lung diseases represented by idiopathic pulmonary fibrosis (IPF), and it is the main cause of respiratory failure and death caused by the irreversible development of such diseases. The pathogenesis remains unclear. Traditional corticosteroids and immunosuppressants in the treatment of diffuse pulmonary interstitial fibrosis are not only ineffective but also have many adverse reactions. Currently, there is no effective treatment other than lung transplantation. Sinomenine is an alkaloid monomer extracted from the traditional Chinese medicinal plant S. chinensis. Studies have found that it has anti-inflammatory, anti-oxidation, immunosuppressive, and analgesic effects. It is used in the treatment of rheumatic diseases such as rheumatoid arthritis. widely used in (Zho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of sinomenine as a medicament for preventing and treating pulmonary interstitial fibrosis. The medicament is prepared by sinomenine or pharmaceutically acceptable salt thereof and other adjuvants, wherein sinomenine or pharmaceutically acceptable salt thereof serves as an activating agent. The routes of administration of the medicament include intravenous drip, intramuscular injection, oral administration, transdermal absorption, atomization inhalation and bronchoalveolar lavage. Experiments show that sinomenine does not have obvious difference with the dexamethasone control group in the effect on inhibiting formation of bleomycin-induced pulmonary fibrosis in mice and prove that sinomenine can alleviate pulmonary alveolitis and fibrosis degrees of themice with bleomycin-induced pulmonary fibrosis and the mechanisms are probably realized by inhibiting expressions of TGF (transforming growth factor)-beta1 and alpha-SMA (smooth muscle actin) and thecontent of HYP (hydroxyproline).

Description

technical field [0001] The present invention relates to an alkaloid used for preventing and treating pulmonary interstitial fibrosis, in particular to sinomenine or its pharmaceutically acceptable salt for preventing and treating pulmonary interstitial fibrosis caused by various chronic inflammatory pathological mechanisms change. Background technique [0002] 1. Pharmacological effects of sinomenine [0003] Sinomenine (sinomenine) is one of the alkaloids extracted from the stem and root of Sinomenium acutum (Thunb.) R.etWils., which is a known medicinal substance. Modern pharmacological studies have shown that sinomenine has a variety of pharmacological effects. In a nutshell, the main pharmacological effects of sinomenine known so far are as follows: anti-inflammatory, immunosuppressive, antihypertensive, central inhibitory, antiarrhythmic, etc. [0004] Sinomenine hydrochloride has the following pharmacological effects: [0005] 1. Anti-inflammatory effect: can inhib...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/485A61K31/473A61P11/00A61P29/00
Inventor 李蕴麟
Owner 李蕴麟
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products